Caxton Associates (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
+2,780
New +$648K 0.01% 476
2026
Q1
Sell
-2,016
Closed -$417K 899
2025
Q4
$417K Sell
2,016
-1,840
-48% -$364K 0.01% 544
2025
Q3
$715K Sell
3,856
-817
-17% -$140K 0.02% 397
2025
Q2
$714K Buy
+4,673
New +$718K 0.02% 363

Other funds holding JNJ

Caxton Associates (UK)'s JNJ Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 2,780 shares worth $706K. The stake represents 0.01% of the portfolio and ranks #476 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in JNJ as recently as Q4 2025.

Caxton Associates (UK) first reported a position in JNJ in Q2 2025 and has held it in 4 quarters since. The position peaked at $715K in Q3 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Caxton Associates (UK) held 2,780 shares of Johnson & Johnson worth $706K as of Q2 2026.
  • Johnson & Johnson was a new Caxton Associates (UK) position in Q2 2026.
  • Johnson & Johnson made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #476 holding.
  • Caxton Associates (UK) first reported a position in Johnson & Johnson in Q2 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Johnson & Johnson position peaked at $715K in Q3 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.